Increased NQO1 but Not c-MET and Survivin Expression in Non-Small Cell Lung Carcinoma with KRAS Mutations

Ahmet Yilmaz, Nehad Mohamed, Kara A. Patterson, Yan Tang, Konstantin Shilo, Miguel A. Villalona-Calero, Michael E. Davis, Xiaoping Zhou, Wendy Frankel, Gregory A. Otterson, Howard D. Beall and Weiqiang Zhao
Additional contact information
Ahmet Yilmaz: Department of Pathology, The Ohio State University, Columbus, OH 43210, USA
Nehad Mohamed: Department of Pathology, The Ohio State University, Columbus, OH 43210, USA
Kara A. Patterson: Department of Pathology, The Ohio State University, Columbus, OH 43210, USA
Yan Tang: Department of Pathology, The Ohio State University, Columbus, OH 43210, USA
Konstantin Shilo: Department of Pathology, The Ohio State University, Columbus, OH 43210, USA
Miguel A. Villalona-Calero: Department of Internal Medicine, The Ohio State University, Columbus, OH 43210, USA
Michael E. Davis: Department of Animal Sciences, The Ohio State University, Columbus, OH 43210, USA
Xiaoping Zhou: Department of Pathology, The Ohio State University, Columbus, OH 43210, USA
Wendy Frankel: Department of Pathology, The Ohio State University, Columbus, OH 43210, USA
Gregory A. Otterson: Department of Internal Medicine, The Ohio State University, Columbus, OH 43210, USA
Howard D. Beall: Department of Pharmaceutical Sciences, School of Pharmacy, The University of Montana, Missoula, MT 59812, USA
Weiqiang Zhao: Department of Pathology, The Ohio State University, Columbus, OH 43210, USA

IJERPH, 2014, vol. 11, issue 9, 1-12

Abstract: Cigarette smoking is one of the most significant public health issues and the most common environmental cause of preventable cancer deaths worldwide. EGFR (Epidermal Growth Factor Receptor)-targeted therapy has been used in the treatment of LC (lung cancer), mainly caused by the carcinogens in cigarette smoke, with variable success. Presence of mutations in the KRAS (Kirsten rat sarcoma viral oncogene homolog) driver oncogene may confer worse prognosis and resistance to treatment for reasons not fully understood. NQO1 (NAD(P)H:quinone oxidoreductase), also known as DT-diaphorase, is a major regulator of oxidative stress and activator of mitomycins, compounds that have been targeted in over 600 pre-clinical trials for treatment of LC. We sequenced KRAS and investigated expression of NQO1 and five clinically relevant proteins (DNMT1, DNMT3a, ERK1/2, c-MET, and survivin) in 108 patients with non-small cell lung carcinoma (NSCLC). NQO1, ERK1/2, DNMT1, and DNMT3a but not c-MET and survivin expression was significantly more frequent in patients with KRAS mutations than those without, suggesting the following: (1) oxidative stress may play an important role in the pathogenesis, worse prognosis, and resistance to treatment reported in NSCLC patients with KRAS mutations, (2) selecting patients based on their KRAS mutational status for future clinical trials may increase success rate, and (3) since oxidation of nucleotides also specifically induces transversion mutations, the high rate of KRAS transversions in lung cancer patients may partly be due to the increased oxidative stress in addition to the known carcinogens in cigarette smoke.

Keywords: lung cancer; non-small cell lung carcinoma; oxidative stress; KRAS; mutation; NQO1; DNA methyl transferase; ERK1/2; c-MET; survivin (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2014
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/11/9/9491/pdf (application/pdf)
https://www.mdpi.com/1660-4601/11/9/9491/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:11:y:2014:i:9:p:9491-9502:d:40200

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().